Position in RCUS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,750,097
+$1,112,472 QoQ
Shares Held
89,202
+17.7% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#73
of 230 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. RCUS ranks #142 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in RCUS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,750,097 | 89,202 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,637,625 | 75,816 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,397,605 | 58,649 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $671,051 | 49,342 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $361,163 | 44,369 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $267,457 | 34,071 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $460,815 | 30,948 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $568,986 | 37,213 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $555,864 | 36,498 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $656,344 | 34,764 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $627,587 | 32,858 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $560,273 | 31,213 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $5,719,702 | 281,620 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,098,626 | 279,530 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $10,458,847 | 505,747 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $625,197 | 23,899 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $448,543 | 17,701 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $613,431 | 19,437 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $720,973 | 17,815 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $648,024 | 18,584 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $511,387 | 18,623 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $596,278 | 21,235 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $551,494 | 21,244 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $195,430 | 11,402 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||